NF1 and breast carcinoma: Based on the well-established susceptibility of the Nf1 mutant background used in our models, we assessed NF1 status in radiation-induced breast cancers from survivors of HD (none having NF1) and found evidence of NF1 loss of heterozygosity (Choi et al., 2012), indicating that this loss occurs in human SMNs.